Clinical Trials Sponsored by Tiziana Life Sciences, PLC

Total 72 results

Tiziana Life Sciences LTD

Withdrawn

A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease

Crohn's Disease
Tiziana Life Sciences LTD

Withdrawn

Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD

Completed

Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Israel, Greece, Italy
Tiziana Life Sciences LTD

Not yet recruiting

Milciclib in Combination With Gemcitabine in Advanced NSCLC

NSCLC
Tiziana Life Sciences LTD

Terminated

Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

Malignant Thymoma

United States, Italy
Tiziana Life Sciences LTD

Terminated

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Thymic Carcinoma

United States, France, Italy
Tiziana Life Sciences LTD

Recruiting

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

Secondary Progressive Multiple Sclerosis

United States
Tiziana Life Sciences LTD

Withdrawn

In-patient COVID-19 Study of Intranasal Foralumab

Covid19 | COVID-19 Respiratory Infection | COVID-19 Lower Respiratory Infection
Tiziana Life Sciences LTD

Withdrawn

Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

NAFLD | NASH - Nonalcoholic Steatohepatitis | T2DM (Type 2 Diabetes Mellitus)
Dharma Life Sciences LLC

Completed

Reducing Anxiety Levels Through the Dharma Life App-Based and Mentor-Based Program Targeting Personality Characteristics: A Randomized Control Trial

Anxiety

United States
Banner Life Sciences LLC

Enrolling by invitation

Observational Study of Persistence on Bafiertam Treatment In Routine Clinical Practice (SIMPLE)

Relapsing Remitting Multiple Sclerosis

United States, Puerto Rico
Banner Life Sciences LLC

Completed

Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects

Relapsing Remitting Multiple Sclerosis
Verily Life Sciences LLC

Completed

Baseline Sleep Apnea Study #2

Obstructive Sleep Apnea of Adult

United States
Banner Life Sciences LLC

Withdrawn

Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate (PERSIST)

Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC

Completed

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

Multiple Sclerosis

United States
MycoMedica Life Sciences PBC

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 in Healthy Participants

Healthy Volunteers

Australia
Verily Life Sciences LLC

Withdrawn

Verily Watch Cardio (AF and ECG) Study

Atrial Fibrillation

United States
Verily Life Sciences LLC

Active, not recruiting

Predictors of Severe COVID-19 Outcomes (PRESCO)

COVID-19 | Acute Respiratory Distress Syndrome

United States
Verily Life Sciences LLC

Not yet recruiting

Verily Clinical Study Watch Analytical Validation Study

Healthy Population

United States
Verily Life Sciences LLC

Recruiting

Study Watch Sleep Metric Performance Characterization Study

Insomnia | Sleep | Obstructive Sleep Apnea

United States
Calico Life Sciences LLC

Available

Expanded Access to ABBV-CLS-484

Advanced Solid Tumor Cancer
Verily Life Sciences LLC

Completed

Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study) (GAIN)

Colon Adenoma | Colon Polyp | Colon Lesion

United States, Israel
Banner Life Sciences LLC

Completed

Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects

Relapsing Remitting Multiple Sclerosis

United States
Verily Life Sciences LLC

Completed

Study Watch AF Detection At Home

Atrial Fibrillation

United States
Verily Life Sciences LLC

Completed

Onduo Virtual Diabetes Clinic Study (VDC)

Diabetes Mellitus, Type 2

United States
Verily Life Sciences LLC

Terminated

A Clinical Data Collection Study of Verily Patch

Febrile | Afebrile

United States
Verily Life Sciences LLC

Completed

Study Watch Atrial Fibrillation (AF) Detection Investigation

Atrial Fibrillation

United States
Calico Life Sciences LLC
AbbVie

Completed

A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262

Healthy

United States
Calico Life Sciences LLC
AbbVie

Recruiting

A Phase 1 Study With ABBV-CLS-484 in Subjects With Locally Advanced or Metastatic Tumors

Advanced Solid Tumor Cancer

United States, Korea, Republic of, Israel, Spain, Japan, France
Calico Life Sciences LLC
AbbVie

Completed

A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects

Healthy

United States
Calico Life Sciences LLC
AbbVie

Recruiting

A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects

Healthy

United States
Calico Life Sciences LLC
AbbVie

Recruiting

An Open-Label Exploratory Study of ABBV-CLS-7262 Subjects With Vanishing White Matter Disease

Vanishing White Matter Disease

United States, Netherlands
Calico Life Sciences LLC
AbbVie

Recruiting

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

Advanced Solid Tumors Cancer

Korea, Republic of, Taiwan, Spain, United States, France, Japan, Israel
Calico Life Sciences LLC
AbbVie

Active, not recruiting

A Phase 1 Study to Investigate the Safety and Pharmacokinetics of ABBV-CLS-7262 in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis | ALS

United States, Canada
SerenaGroup, Inc.
Lacerta Life Sciences, LLC

Not yet recruiting

Clinical Trial Evaluating a Hyaluronic Acid Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs)

Diabetic Foot
BioTeke USA, LLC
CSSi Life Sciences

Completed

Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test

COVID-19

United States
Verily Life Sciences LLC
The Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation

Completed

ARDA Software for the Detection of mtmDR

Diabetic Retinopathy

United States
ReAlta Life Sciences, Inc.
Premier Research Group plc

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia (STAR)

Hypoxic-Ischemic Encephalopathy

United States
Pharmtechnology LLC
Reliance Life Sciences Private Limited

Completed

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

Healthy

India
SCRI Development Innovations, LLC
Achieve Life Sciences

Completed

Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer (Spruce)

Non Squamous Non Small Cell Lung Cancer

United States
Medical Group Care, LLC
CSSi Life Sciences

Completed

MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

COVID-19 | Influenza A | Influenza B

United States
SCRI Development Innovations, LLC
Achieve Life Sciences

Completed

Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer (Rainier)

Pancreatic Cancer

United States
PTC Therapeutics
Parexel; Dohmen Life Science Services

Approved for marketing

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

United States
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects

Healthy

United States
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Multiple-Dose Study of VGX-1027 in Healthy Subjects

Healthy

United States
Radboud University Medical Center
Verily Life Sciences LLC

Recruiting

The ADAPT-study: Measuring Physical Performance Using Wearable Sensors in Parkinson's Disease and COPD (ADAPT) (ADAPT)

Parkinson Disease | COPD

Netherlands
Brigham and Women's Hospital
Tersus Life Sciences LLC

Recruiting

Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes

Obesity | Overweight | Insulin Resistance | PreDiabetes

United States
Chinese PLA General Hospital
Likang Life Sciences Holdings Limited

Unknown

A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer, Adult

China
Cancer Insight, LLC
Genentech, Inc.; Sellas Life Sciences Group

Completed

Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients (HER3+)

Breast Cancer

United States
Sellas Life Sciences Group
Merck Sharp & Dohme LLC; Cancer Insight, LLC

Active, not recruiting

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Colorectal Cancer | Ovarian Cancer | Acute Myelogenous Leukemia | Small-cell Lung Cancer | Triple-negative Breast Cancer

United States

Clinical Trials Sponsored by Tiziana Life Sciences, PLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations